Home Capital Group Inc.: Where Have All the Bulls Run?

Home Capital Group Inc. (TSX:HCG) has officially turned sour, and investors are exiting positions in this once-promising lender in Canada’s high interest rate non-prime category.

| More on:

Home Capital Group Inc. (TSX:HCG) has officially turned sour, and investors are exiting positions in this once-promising lender in Canada’s high interest rate non-prime category.

I am a believer that one of the most valuable traits any investor can have is the ability to change one’s mind about an investment on evidence contrary to one’s viewpoint. The ability to reverse course and cut losses before an investment turns into a complete disaster can mean the difference between making money and losing money in a given year.

Long-term investors often have no choice but to hold steadfast on an industry or a group of stocks during a prolonged downturn with the confidence that the investment will turn around based on solid underlying fundamentals. When the fundamentals of an industry change, however, the best investors are often the fleetest of foot, getting out when others are adding to value-trap positions.

Case in point: Warren Buffett’s exit of Wal-Mart Stores Inc. along with a surprising 180-degree shift toward the U.S. airline industry have investors talking. Here is a world-class investor with an iconic long-term investment strategy that has completely shifted his views on bricks-and-mortar retailing and the aerospace industry.

Other iconic investors, such as Bill Ackman, who have stuck to their guns with investments in clunkers such as Valeant Pharmaceuticals Intl Inc., have paid a hefty price for this lack of strategic agility. Ackman’s loss on Valeant has been calculated at more than $4 billion, according to sources.

Bottom line

The investors bullish on Home Capital’s prospects have seemingly dissipated. Repeatedly shouting “value” and “low price-to-earnings ratio” won’t make value appear. Sometimes a company has cracks in its foundation, and when a business’s fundamentals are failing, even the most bullish investors should take inventory of the issues and carefully analyze the causes and potential future impact of the adjusted fundamentals.

The market has taken its time in adjusting to the reality that Home Capital is in hot water, and while some Home Capital supporters have claimed that the decline in the company’s stock price is due to unfair speculation, short sellers from south of the border, or just plain “bad news,” the reality is that each of the scandals that have plagued the company of late cumulatively add up to the following:

  • High probability of increased costs for the company via increased deposit rates;
  • High probability of material decreases in loan origination due to reputation-related issues;
  • Significant likelihood that increased scrutiny and an OSC investigation into the company’s lending practices will uncover additional regulatory issues; and
  • Increased likelihood of a downgrade to non-investment-grade status, increasing borrowing costs and reducing or eliminating institutional investor interest.

All things being equal, Home Capital is a company that has a long and difficult road ahead. It appears that a key driver behind the recent plunge in the company’s stock price is that investors have just started to notice.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of HOME CAPITAL GROUP INC. and Valeant Pharmaceuticals.

More on Dividend Stocks

Increasing yield
Dividend Stocks

2 High-Yield Stocks: 1 to Buy and 1 to Avoid

Not every high-yield stock is a buy. Get a holistic view of business operations, economics, and demand and supply environment…

Read more »

gas station, car, and 24-hour store
Dividend Stocks

Alimentation Couche-Tard: Buy, Sell, or Hold?

Alimentation Couche-Tard (TSX:ATD) has had a great run historically. Will it continue?

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

How Retirees Can Use the TFSA to Earn $5,000 Per Year in Tax-Free Passive Income and Avoid the OAS Clawback

This strategy reduces risk while boosting TFSA yield.

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TSX Bargains: 2 Stocks Near 52-Week Lows (for Now)

Cascades (TSX:CAS) and another top stock that long-term investors should look to for deeply-undervalued sales growth bounce-back potential.

Read more »

edit Person using calculator next to charts and graphs
Dividend Stocks

Finning Stock Jumps on Strong Earnings and a 10% Dividend Bump

Finning (TSX:FTT) stock saw shares climb higher on strong first-quarter earnings coupled with a dividend increase of 10%.

Read more »

potted green plant grows up in arrow shape
Dividend Stocks

RRSP Deals: 2 Dividend-Growth Stocks to Buy on the Dip and Own for Decades

Top TSX dividend stocks now offer attractive yields.

Read more »

Man making notes on graphs and charts
Dividend Stocks

If I Could Only Buy 3 Stocks in 2024, I’d Pick These

Brookfield (TSX:BN) is one of the stocks I'd buy if I could buy just three.

Read more »

Senior Couple Walking With Pet Bulldog In Countryside
Dividend Stocks

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

Want to generate decades of passive income? Here's a trio of stocks that can help you accomplish that goal over…

Read more »